www.fdanews.com/articles/101737-oncovista-licenses-cancer-drug-compound-from-new-york-firm

OncoVista Licenses Cancer Drug Compound From New York Firm

December 3, 2007

OncoVista Inc. has signed an exclusive worldwide agreement to license a cancer drug candidate from OSI Pharmaceuticals Inc. Terms of the licensing agreement were not disclosed.
San Antonio Business Journal